David Moatazedi - May 8, 2023 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jeffrey J. Plumer, as attorney-in-fact for David Moatazedi
Stock symbol
EOLS
Transactions as of
May 8, 2023
Transactions value $
$0
Form type
4
Date filed
5/9/2023, 06:21 PM
Previous filing
Mar 29, 2023
Next filing
Aug 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EOLS Restricted Stock Units Award $0 +560K $0.00 560K May 8, 2023 Common Stock 560K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance-based restricted stock unit represents a contingent right to receive one share of the EOLS common stock.
F2 40% of the stock units are eligible to vest if the average EOLS common stock closing price over 20 consecutive trading days is $30 or more and an additional 60% of the stock units are eligible to vest if the average EOLS common stock closing price over 20 consecutive trading days is $50 or more, in each case not later than five years after the grant of the award. Any units eligible to vest based on stock price will vest, subject to continued service, over the four-year period after the grant date.

Remarks:

President and Chief Executive Officer